Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade

Circulation

Volumn 135, Issue 11, 2017, Pages 1075-1092

  Noel Bairey Merz, C ^a   Pepine, Carl J ^b   Walsh, Mary Norine ^c   Fleg, Jerome L ^d  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c St Vincent Renal Transplant Program   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

heart diseases; ischemia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANGINA PECTORIS AGENT; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADVERSE OUTCOME; AGE; ARTICLE; ATHEROSCLEROSIS; AUTONOMIC NERVOUS SYSTEM; BLOOD CLOTTING DISORDER; BLOOD PRESSURE; BLOOD VESSEL; CARDIOVASCULAR MAGNETIC RESONANCE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; HEALTH CARE COST; HEART MUSCLE ISCHEMIA; HUMAN; INVASIVE PROCEDURE; MANAGED CARE; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; THROMBOCYTE DYSFUNCTION; CARDIOVASCULAR DISEASES; COMORBIDITY; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; EVIDENCE BASED PRACTICE; FACTUAL DATABASE; PHYSIOLOGY; RISK FACTOR;

AGE FACTORS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COMORBIDITY; CORONARY VESSELS; DATABASES, FACTUAL; EVIDENCE-BASED PRACTICE; HUMANS; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SEX FACTORS;

EID: 85015158337     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.024534     Document Type: Article

References (144)

1. Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, Cole J, Dolor RJ, Fordyce CB, Huang M, Khan MA, Kosinski AS, Krucoff MW, Malhotra V, Picard MH, Udelson JE, Velazquez EJ, Yow E, Cooper LS, Lee KL, PROMISE Investigators Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015 372 1291 1300. doi: 10.1056/NEJMoa1415516
2. Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, Jørgensen E, Kelbæk H, Prescott E, Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 2012 33 734 744. doi: 10.1093/eurheartj/ehr331
3. Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ, Leon B, Bhatt DL, Fihn SD, Rumsfeld JS, Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA 2014 312 1754 1763. doi: 10.1001/jama.2014.14681
4. Pepine CJ, Ferdinand KC, Shaw LJ, Light-McGroary KA, Shah RU, Gulati M, Duvernoy C, Walsh MN, Bairey Merz CN, ACC CVD in Women Committee Emergence of nonobstructive coronary artery disease: a woman's problem and need for change in definition on angiography. J Am Coll Cardiol 2015 66 1918 1933. doi: 10.1016/j.jacc.2015.08.876
5. Ouldzein H, Elbaz M, Roncalli J, Cagnac R, Carrié D, Puel J, Alibelli-Chemarin MJ, Plaque rupture and morphological characteristics of the culprit lesion in acute coronary syndromes without significant angiographic lesion: analysis by intravascular ultrasound. Ann Cardiol Angeiol (Paris) 2012 61 20 26. doi: 10.1016/j.ancard.2011.07.011
6. Reynolds HR, Srichai MB, Iqbal SN, Slater JN, Mancini GB, Feit F, Pena-Sing I, Axel L, Attubato MJ, Yatskar L, Kalhorn RT, Wood DA, Lobach IV, Hochman JS, Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation 2011 124 1414 1425. doi: 10.1161/CIRCULATIONAHA.111.026542
7. Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P, WG on Cardiovascular Pharmacotherapy ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 2017 38 143 153. doi: 10.1093/eurheartj/ehw149
8. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006 47 suppl S21 S29. doi: 10.1016/j.jacc.2004.12.084
9. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED, Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 2008 117 1787 1801
10. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN, Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009 169 843 850. doi: 10.1001/archinternmed.2009.50
11. Jespersen L, Abildstrom SZ, Hvelplund A, Madsen JK, Galatius S, Pedersen F, Hojberg S, Prescott E, Burden of hospital admission and repeat angiography in angina pectoris patients with and without coronary artery disease: a registry-based cohort study. PLoS One 2014 9 e93170. doi: 10.1371/journal.pone.0093170
12. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 2016 133 e38 e360. doi: 10.1161/CIR.0000000000000350
13. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006 47 suppl S4 S20. doi: 10.1016/j.jacc.2005.01.072
14. Sullivan AK, Holdright DR, Wright CA, Sparrow JL, Cunningham D, Fox KM, Chest pain in women: clinical, investigative, and prognostic features. BMJ 1994 308 883 886
15. Eastwood JA, Johnson BD, Rutledge T, Bittner V, Whittaker KS, Krantz DS, Cornell CE, Eteiba W, Handberg E, Vido D, Bairey Merz CN, Anginal symptoms, coronary artery disease, and adverse outcomes in black and white women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) 2013 22 724 732. doi: 10.1089/jwh.2012.4031
16. Kothawade K, Bairey Merz CN, Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol 2011 36 291 318. doi: 10.1016/j.cpcardiol.2011.05.002
17. Sharaf B, Wood T, Shaw L, Johnson BD, Kelsey S, Anderson RD, Pepine CJ, Bairey Merz CN, Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. Am Heart J 2013 166 134 141. doi: 10.1016/j.ahj.2013.04.002
18. Sedlak TL, Lee M, Izadnegahdar M, Merz CN, Gao M, Humphries KH, Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J 2013 166 38 44. doi: 10.1016/j.ahj.2013.03.015
19. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines T, Berman DS, CONFIRM Investigators Age-and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings: results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol 2011 58 849 860. doi: 10.1016/j.jacc.2011.02.074
20. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, Rogers WJ, Mankad S, Sharaf BL, Bittner V, Bairey Merz CN, Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) Study. Eur Heart J 2006 27 1408 1415. doi: 10.1093/eurheartj/ehl040
21. Leipsic J, Taylor CM, Gransar H, Shaw LJ, Ahmadi A, Thompson A, Humphries K, Berman DS, Hausleiter J, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chow BJ, Cury RC, Delago AJ, Dunning AL, Feuchtner GM, Hadamitzky M, Kaufmann PA, Lin FY, Chinnaiyan KM, Maffei E, Raff GL, Villines TC, Gomez MJ, Min JK, Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology 2014 273 393 400. doi: 10.1148/radiol.14140269
22. Lee BK, Lim HS, Fearon WF, Yong AS, Yamada R, Tanaka S, Lee DP, Yeung AC, Tremmel JA, Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation 2015 131 1054 1060. doi: 10.1161/CIRCULATIONAHA.114.012636
23. Pepine CJ, Multiple causes for ischemia without obstructive coronary artery disease: not a short list. Circulation 2015 131 1044 1046. doi: 10.1161/CIRCULATIONAHA.115.015553
24. Camici PG, Crea F, Coronary microvascular dysfunction. N Engl J Med 2007 356 830 840. doi: 10.1056/NEJMra061889
25. Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, Ruddy TD, Sarveswaran N, Tee RE, Beanlands RS, Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011 58 740 748. doi: 10.1016/j.jacc.2011.01.065
26. Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, Blankstein R, Dorbala S, Sitek A, Pencina MJ, Di Carli MF, Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011 124 2215 2224. doi: 10.1161/CIRCULATIONAHA.111.050427
27. Fukushima K, Javadi MS, Higuchi T, Lautamäki R, Merrill J, Nekolla SG, Bengel FM, Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med 2011 52 726 732. doi: 10.2967/jnumed.110.081828
28. Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, Dorbala S, Blankstein R, Di Carli MF, Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015 131 19 27. doi: 10.1161/CIRCULATIONAHA.114.011939
29. Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, Dorbala S, Blankstein R, Di Carli MF, Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012 126 1858 1868. doi: 10.1161/CIRCULATIONAHA.112.120402
30. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, Johnson BD, Sopko G, Bairey Merz CN, Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010 55 2825 2832. doi: 10.1016/j.jacc.2010.01.054
31. Balázs E, Pintér KS, Egyed Á Csanády M, Forster T, Nemes A, The independent long-term prognostic value of coronary flow velocity reserve in female patients with chest pain and negative coronary angiograms (results from the SZEGED study). Int J Cardiol 2011 146 259 261. doi: 10.1016/j.ijcard.2010.10.071
32. Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, Dorbala S, Blankstein R, Rimoldi O, Camici PG, Di Carli MF, Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014 129 2518 2527. doi: 10.1161/CIRCULATIONAHA.113.008507
33. Britten MB, Zeiher AM, Schächinger V, Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 2004 15 259 264
34. Schindler TH, Cardenas J, Prior JO, Facta AD, Kreissl MC, Zhang XL, Sayre J, Dahlbom M, Licinio J, Schelbert HR, Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol 2006 47 1188 1195. doi: 10.1016/j.jacc.2005.10.062
35. Rigo F, Sicari R, Gherardi S, Djordjevic-Dikic A, Cortigiani L, Picano E, Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter. Am J Cardiol 2007 100 1527 1531. doi: 10.1016/j.amjcard.2007.06.060
36. Nemes A, Forster T, Geleijnse ML, Soliman OI, Cate FJ, Csanády M, Prognostic role of aortic atherosclerosis and coronary flow reserve in patients with suspected coronary artery disease. Int J Cardiol 2008 131 45 50. doi: 10.1016/j.ijcard.2007.08.137
37. 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009 54 150 156. doi: 10.1016/j.jacc.2009.02.069
38. Tio RA, Dabeshlim A, Siebelink HM, de Sutter J, Hillege HL, Zeebregts CJ, Dierckx RA, van Veldhuisen DJ, Zijlstra F, Slart RH, Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009 50 214 219. doi: 10.2967/jnumed.108.054395
39. Cortigiani L, Rigo F, Gherardi S, Galderisi M, Bovenzi F, Picano E, Sicari R, Prognostic effect of coronary flow reserve in women versus men with chest pain syndrome and normal dipyridamole stress echocardiography. Am J Cardiol 2010 106 1703 1708. doi: 10.1016/j.amjcard.2010.08.011
40. Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, Ruddy TD, Sarveswaran N, Tee RE, Beanlands RS, Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011 58 740 748. doi: 10.1016/j.jacc.2011.01.065
41. Jones E, Eteiba W, Merz NB, Cardiac syndrome X and microvascular coronary dysfunction. Trends Cardiovasc Med 2012 22 161 168. doi: 10.1016/j.tcm.2012.07.014
42. Taqueti VR, Shaw LJ, Cook NR, Murthy VL, Shah NR, Foster CR, Hainer J, Blankstein R, Dorbala S, Di Carli MF, Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 2017 135 566 577. doi: 10.1161/CIRCULATIONAHA.116.023266
43. Crea F, Camici PG, Bairey Merz CN, Coronary microvascular dysfunction: an update. Eur Heart J 2014 35 1101 1111. doi: 10.1093/eurheartj/eht513
44. Moreau P, d'Uscio LV, Lüscher TF, Structure and reactivity of small arteries in aging. Cardiovasc Res 1998 37 247 253
45. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozàkovà M, La Canna G, Nardi M, Guelfi D, Salvetti M, Morizzo C, Vittone F, Rosei EA, Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003 21 625 631. doi: 10.1097/01.hjh.0000052467.40108.a7
46. Smith SM, Huo T, Delia Johnson B, Bittner V, Kelsey SF, Vido Thompson D, Noel Bairey Merz C, Pepine CJ, Cooper-Dehoff RM, Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study. J Am Heart Assoc 2014 3 e000660. doi: 10.1161/JAHA.113.000660
47. Sucato V, Evola S, Novo G, Novo S, Diagnosis of coronary microvascualar dysfunction in diabetic patients with cardiac syndrome X: comparison by current methods [in Italian]. Recenti Prog Med 2013 104 63 68. doi: 10.1701/1241.13706
48. Maseri A, Crea F, Kaski JC, Crake T, Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991 17 499 506
49. Di Carli MF, Janisse J, Grunberger G, Ager J, Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003 41 1387 1393
50. Kaufmann PA, Gnecchi-Ruscone T, Schäfers KP, Lüscher TF, Camici PG, Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000 36 103 109
51. Wessel TR, Arant CB, McGorray SP, Sharaf BL, Reis SE, Kerensky RA, von Mering GO, Smith KM, Pauly DF, Handberg EM, Mankad S, Olson MB, Johnson BD, Merz CN, Sopko G, Pepine CJ, NHLBI Women's Ischemia Syndrome Evaluation (WISE) Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE). Clin Cardiol 2007 30 69 74. doi: 10.1002/clc.19
52. Recio-Mayoral A, Rimoldi OE, Camici PG, Kaski JC, Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging 2013 6 660 667. doi: 10.1016/j.jcmg.2012.12.011
53. Cosín-Sales J, Pizzi C, Brown S, Kaski JC, C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol 2003 41 1468 1474
54. Sakr SA, Abbas TM, Amer MZ, Dawood EM, El-Shahat N, Abdel Aal IA, Ramadan MM, Microvascular angina: the possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J 2009 50 407 419
55. Ong P, Sivanathan R, Borgulya G, Bizrah M, Iqbal Y, Andoh J, Gaze D, Kaski JC, Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X). Cardiovasc Drugs Ther 2012 26 239 244. doi: 10.1007/s10557-012-6382-4
56. Teragawa H, Fukuda Y, Matsuda K, Ueda K, Higashi Y, Oshima T, Yoshizumi M, Chayama K, Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart 2004 90 750 754. doi: 10.1136/hrt.2003.022269
57. Ishimori ML, Martin R, Berman DS, Goykhman P, Shaw LJ, Shufelt C, Slomka PJ, Thomson LE, Schapira J, Yang Y, Wallace DJ, Weisman MH, Bairey Merz CN, Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging 2011 4 27 33. doi: 10.1016/j.jcmg.2010.09.019
58. Hahn VS, Lenihan DJ, Ky B, Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies. J Am Heart Assoc 2014 3 e000665. doi: 10.1161/JAHA.113.000665
59. Recio-Mayoral A, Mason JC, Kaski JC, Rubens MB, Harari OA, Camici PG, Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J 2009 30 1837 1843. doi: 10.1093/eurheartj/ehp205
60. Nichols WW, Denardo SJ, Davidson JB, Huo T, Bairey Merz CN, Pepine CJ, Association of aortic stiffness and wave reflections with coronary flow reserve in women without obstructive coronary artery disease: an ancillary study from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 2015 170 1243 1254. doi: 10.1016/j.ahj.2015.08.019
61. Redheuil A, Yu WC, Wu CO, Mousseaux E, de Cesare A, Yan R, Kachenoura N, Bluemke D, Lima JA, Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension 2010 55 319 326. doi: 10.1161/HYPERTENSIONAHA.109.141275
62. Libby P, Pasterkamp G, Requiem for the "vulnerable plaque." Eur Heart J 2015 36 2984 2987. doi: 10.1093/eurheartj/ehv349
63. Vitiello L, Spoletini I, Gorini S, Pontecorvo L, Ferrari D, Ferraro E, Stabile E, Caprio M, La Sala A, Microvascular inflammation in atherosclerosis. IJC Metab Endocr 2014 3 1 7
64. Khuddus MA, Pepine CJ, Handberg EM, Bairey Merz CN, Sopko G, Bavry AA, Denardo SJ, McGorray SP, Smith KM, Sharaf BL, Nicholls SJ, Nissen SE, Anderson RD, An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol 2010 23 511 519. doi: 10.1111/j.1540-8183.2010.00598.x
65. Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW, Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study: Coronary Artery Surgery Study. J Am Coll Cardiol 1995 25 1000 1009
66. Fisher LD, Judkins MP, Lesperance J, Cameron A, Swaye P, Ryan T, Maynard C, Bourassa M, Kennedy JW, Gosselin A, Kemp H, Faxon D, Wexler L, Davis KB, Reproducibility of coronary arteriographic reading in the Coronary Artery Surgery Study (CASS). Cathet Cardiovasc Diagn 1982 8 565 575
67. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL, Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986 7 479 483
68. Petersen JW, Johnson BD, Kip KE, Anderson RD, Handberg EM, Sharaf B, Mehta PK, Kelsey SF, Merz CN, Pepine CJ, TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). PLoS One 2014 9 e96630. doi: 10.1371/journal.pone.0096630
69. Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J, Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999 99 2871 2875
70. Wei J, Nelson MD, Szczepaniak EW, Smith L, Mehta PK, Thomson LE, Berman DS, Li D, Bairey Merz CN, Szczepaniak LS, Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women. Am J Physiol Heart Circ Physiol 2016 310 H14 H19. doi: 10.1152/ajpheart.00612.2015
71. Colom B, Oliver J, Garcia-Palmer FJ, Sexual dimorphism in the alterations of cardiac muscle mitochondrial bioenergetics associated to the ageing process. J Gerontol A Biol Sci Med Sci 2015 70 1360 1369. doi: 10.1093/gerona/glu014
72. Eroglu S, Sade LE, Bozbas H, Haberal A, Ozbicer S, Demir O, Muderrisoglu H, Association of serum adiponectin levels and coronary flow reserve in women with normal coronary angiography. Eur J Cardiovasc Prev Rehabil 2009 16 290 296. doi: 10.1097/HJR.0b013e32831f1b8a
73. Regensteiner JG, Golden S, Huebschmann AG, Barrett-Connor E, Chang AY, Chyun D, Fox CS, Kim C, Mehta N, Reckelhoff JF, Reusch JE, Rexrode KM, Sumner AE, Welty FK, Wenger NK, Anton B, Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation 2015 132 2424 2447
74. Di Carli MF, Charytan D, McMahon GT, Ganz P, Dorbala S, Schelbert HR, Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med 2011 52 1369 1377. doi: 10.2967/jnumed.110.082883
75. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, Rossen JD, Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995 91 635 640
76. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J, ADMIRE-HF Investigators Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010 55 2212 2221. doi: 10.1016/j.jacc.2010.01.014
77. 123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation 1997 96 821 826
78. Mehta PK, Nelson M, Thomson L, Friedman J, Hayes S, Hermel D, Slomka P, Swift A, Wei J, Cook-Wiens G, Sayari S, Irwin MR, Krantz D, Travin M, Berman D, Bairey Merz CN, Abnormal cardiac sympathetic activity detected by 123-I-meta-iodobenzylguanidine imaging in women with signs and symptoms of ischemia and no obstructive coronary artery disease. J Am Coll Cardiol 2016 67 suppl 1619
79. Klabunde RE, Cardiovascular Physiology Concepts 2005 1st ed Philadelphia, PA Lippincott
80. Muller MD, Gao Z, McQuillan PM, Leuenberger UA, Sinoway LI, Coronary responses to cold air inhalation following afferent and efferent blockade. Am J Physiol Heart Circ Physiol 2014 307 H228 H235. doi: 10.1152/ajpheart.00174.2014
81. Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, Levine TB, Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997 336 1208 1215. doi: 10.1056/NEJM199704243361703
82. Harris KF, Matthews KA, Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease. Psychosom Med 2004 66 153 164
83. Dakak N, Quyyumi AA, Eisenhofer G, Goldstein DS, Cannon RO 3rd, Sympathetically mediated effects of mental stress on the cardiac microcirculation of patients with coronary artery disease. Am J Cardiol 1995 76 125 130
84. Rimoldi O, Spyrou N, Foale R, Hackett DR, Gregorini L, Camici PG, Limitation of coronary reserve after successful angioplasty is prevented by oral pretreatment with an alpha1-adrenergic antagonist. J Cardiovasc Pharmacol 2000 36 310 315
85. Lanza GA, Andreotti F, Sestito A, Sciahbasi A, Crea F, Maseri A, Platelet aggregability in cardiac syndrome X. Eur Heart J 2001 22 1924 1930. doi: 10.1053/euhj.2001.2624
86. Lanza GA, Aurigemma C, Fattorossi A, Scambia G, Crea F, Changes in platelet receptor expression and leukocyte-platelet aggregate formation following exercise in Cardiac Syndrome X. J Thromb Haemost 2006 4 1623 1625. doi: 10.1111/j.1538-7836.2006.02003.x
87. Aurigemma C, Scalone G, Fattorossi A, Sestito A, Lanza GA, Crea F, Adenosine inhibition of adenosine diphosphate and thrombin-induced monocyte-platelet aggregates in cardiac syndrome X. Thromb Res 2009 124 116 120. doi: 10.1016/j.thromres.2008.12.041
88. Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S, Hill S, Schäufele T, Mahrholdt H, Kaski JC, Sechtem U, Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation 2014 129 1723 1730. doi: 10.1161/CIRCULATIONAHA.113.004096
89. Reriani M, Sara JD, Flammer AJ, Gulati R, Li J, Rihal C, Lennon R, Lerman LO, Lerman A, Coronary endothelial function testing provides superior discrimination compared with standard clinical risk scoring in prediction of cardiovascular events. Coron Artery Dis 2016 27 213 220. doi: 10.1097/MCA.0000000000000347
90. Wei J, Mehta PK, Johnson BD, Samuels B, Kar S, Anderson RD, Azarbal B, Petersen J, Sharaf B, Handberg E, Shufelt C, Kothawade K, Sopko G, Lerman A, Shaw L, Kelsey SF, Pepine CJ, Merz CN, Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv 2012 5 646 653. doi: 10.1016/j.jcin.2012.01.023
91. Taqueti VR, Everett BM, Murthy VL, Gaber M, Foster CR, Hainer J, Blankstein R, Dorbala S, Di Carli MF, Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation 2015 131 528 535. doi: 10.1161/CIRCULATIONAHA.114.009716
92. Mygind ND, Michelsen MM, Pena A, Frestad D, Dose N, Aziz A, Faber R, Høst N, Gustafsson I, Hansen PR, Hansen HS, Bairey Merz CN, Kastrup J, Prescott E, Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and no obstructive coronary artery disease: the iPOWER Study. J Am Heart Assoc 2016 5 e003064. doi: 10.1161/JAHA.115.003064
93. Lanza GA, Buffon A, Sestito A, Natale L, Sgueglia GA, Galiuto L, Infusino F, Mariani L, Centola A, Crea F, Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 2008 51 466 472. doi: 10.1016/j.jacc.2007.08.060
94. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ, Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002 346 1948 1953. doi: 10.1056/NEJMoa012369
95. Thomson LE, Wei J, Agarwal M, Haft-Baradaran A, Shufelt C, Mehta PK, Gill EB, Johnson BD, Kenkre T, Handberg EM, Li D, Sharif B, Berman DS, Petersen JW, Pepine CJ, Bairey Merz CN, Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging 2015 8 e002481.
96. Ballantyne CM, Raichlen JS, Nicholls SJ, Erbel R, Tardif JC, Brener SJ, Cain VA, Nissen SE, ASTEROID Investigators Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation 2008 117 2458 2466. doi: 10.1161/CIRCULATIONAHA.108.773747
97. Dupuis J, Tardif JC, Cernacek P, Théroux P, Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE (Reduction of Cholesterol in Ischemia and Function of the Endothelium) trial. Circulation 1999 99 3227 3233
98. Ridker PM, MacFadyen J, Libby P, Glynn RJ, Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Am J Cardiol 2010 106 204 209. doi: 10.1016/j.amjcard.2010.03.018
99. Zhang X, Li Q, Zhao J, Li X, Sun X, Yang H, Wu Z, Yang J, Effects of combination of statin and calcium channel blocker in patients with cardiac syndrome X. Coron Artery Dis 2014 25 40 44. doi: 10.1097/MCA.0000000000000054
100. Caliskan M, Erdogan D, Gullu H, Topcu S, Ciftci O, Yildirir A, Muderrisoglu H, Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol 2007 30 475 479. doi: 10.1002/clc.20140
101. Eshtehardi P, McDaniel MC, Dhawan SS, Binongo JN, Krishnan SK, Golub L, Corban MT, Raggi P, Quyyumi AA, Samady H, Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function. J Invasive Cardiol 2012 24 522 529
102. Pizzi C, Manfrini O, Fontana F, Bugiardini R, Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation 2004 109 53 58. doi: 10.1161/01.CIR.0000100722.34034.E4
103. Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Merz CN, Pepine CJ, In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: a double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 2011 162 678 684. doi: 10.1016/j.ahj.2011.07.011
104. Schwartzkopff B, Brehm M, Mundhenke M, Strauer BE, Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. Hypertension 2000 36 220 225
105. Bavry AA, Handberg EM, Huo T, Lerman A, Quyyumi AA, Shufelt C, Sharaf B, Merz CN, Cooper-DeHoff RM, Sopko G, Pepine CJ, Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Am Heart J 2014 167 826 832. doi: 10.1016/j.ahj.2014.01.017
106. Garg R, Rao AD, Baimas-George M, Hurwitz S, Foster C, Shah RV, Jerosch-Herold M, Kwong RY, Di Carli MF, Adler GK, Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes 2015 64 236 242. doi: 10.2337/db14-0670
107. Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK, Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-l-arginine methyl ester-induced myocardial injury. Circulation 2003 108 2517 2523. doi: 10.1161/01.CIR.0000097000.51723.6F
108. Farquharson CA, Struthers AD, Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci (Lond) 2002 103 425 431. doi: 10.1042/
109. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, Fonarow GC, Lange RA, Levine GN, Maddox TM, Naidu SS, Ohman EM, Smith PK, 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2014 130 1749 1767. doi: 10.1161/CIR.0000000000000095
110. Mehta PK, Bairey Merz CN, Treatment of angina in subjects with evidence of myocardial ischemia and no obstructive coronary artery disease. Braunwald's Heart Disease 2011 9th ed Philadelphia, PA Elsevier
111. Kemp HG Jr, Vokonas PS, Cohn PF, Gorlin R, The anginal syndrome associated with normal coronary arteriograms: report of a six year experience. Am J Med 1973 54 735 742
112. Marinescu MA, Löffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM, Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging 2015 8 210 220. doi: 10.1016/j.jcmg.2014.12.008
113. Mizuno R, Fujimoto S, Saito Y, Okamoto Y, Optimal antihypertensive level for improvement of coronary microvascular dysfunction: the lower, the better? Hypertension 2012 60 326 332. doi: 10.1161/HYPERTENSIONAHA.111.189209
114. Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N, Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2006 48 956 963. doi: 10.1016/j.jacc.2006.04.088
115. Lim TK, Choy AJ, Khan F, Belch JJ, Struthers AD, Lang CC, Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. Cardiovasc Ther 2009 27 49 58. doi: 10.1111/j.1755-5922.2008.00070.x
116. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S, INTERHEART Investigators Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008 29 932 940. doi: 10.1093/eurheartj/ehn018
117. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC, Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000 343 16 22. doi: 10.1056/NEJM200007063430103
118. Parikh P, McDaniel MC, Ashen MD, Miller JI, Sorrentino M, Chan V, Blumenthal RS, Sperling LS, Diets and cardiovascular disease: an evidence-based assessment. J Am Coll Cardiol 2005 45 1379 1387. doi: 10.1016/j.jacc.2004.11.068
119. Lanza GA, Colonna G, Pasceri V, Maseri A, Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999 84 854 866, A8
120. Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL, Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance. Cardiologia 1999 44 1065 1069
121. Matsuda Y, Akita H, Terashima M, Shiga N, Kanazawa K, Yokoyama M, Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease. Am Heart J 2000 140 753 759. doi: 10.1067/mhj.2000.110093
122. Sütsch G, Oechslin E, Mayer I, Hess OM, Effect of diltiazem on coronary flow reserve in patients with microvascular angina. Int J Cardiol 1995 52 135 143
123. Cannon RO 3rd, Watson RM, Rosing DR, Epstein SE, Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol 1985 56 242 246
124. Hasenfuss G, Maier LS, Mechanism of action of the new anti-ischemia drug ranolazine. Clin Res Cardiol 2008 97 222 226. doi: 10.1007/s00392-007-0612-y
125. Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, Bairey Merz CN, Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 2011 4 514 522. doi: 10.1016/j.jcmg.2011.03.007
126. Villano A, Di Franco A, Nerla R, Sestito A, Tarzia P, Lamendola P, Di Monaco A, Sarullo FM, Lanza GA, Crea F, Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol 2013 112 8 13. doi: 10.1016/j.amjcard.2013.02.045
127. Bairey Merz CN, Handberg EM, Shufelt CL, Mehta PK, Minissian MB, Wei J, Thomson LE, Berman DS, Shaw LJ, Petersen JW, Brown GH, Anderson RD, Shuster JJ, Cook-Wiens G, Rogatko A, Pepine CJ, A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. Eur Heart J 2016 37 1504 1513. doi: 10.1093/eurheartj/ehv647
128. Skalidis EI, Hamilos MI, Chlouverakis G, Zacharis EA, Vardas PE, Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. Atherosclerosis 2011 215 160 165. doi: 10.1016/j.atherosclerosis.2010.11.035
129. Yeşildaǧ O, Yazici M, Yilmaz O, Uçar R, Saǧkan O, The effect of aminophylline infusion on the exercise capacity in patients with syndrome X. Acta Cardiol 1999 54 335 337
130. Elliott PM, Krzyzowska-Dickinson K, Calvino R, Hann C, Kaski JC, Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart 1997 77 523 526
131. Shi J, Wei L, Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil. J Cardiovasc Pharmacol 2013 62 341 354. doi: 10.1097/FJC.0b013e3182a3718f
132. Mohri M, Shimokawa H, Hirakawa Y, Masumoto A, Takeshita A, Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 2003 41 15 19
133. Palmer RM, Ashton DS, Moncada S, Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988 333 664 666. doi: 10.1038/333664a0
134. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A, Effects of l-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation 1996 94 130 134
135. Gellman J, Hare JM, Lowenstein CJ, Gerstenblith G, Coombs V, Langenberg P, Brinker JA, Resar JR, l-Arginine ameliorates the abnormal sympathetic response of the dysfunctional human coronary microvasculature. Angiology 2004 55 1 8
136. Lerman A, Burnett JC Jr, Higano ST, McKinley LJ, Holmes DR Jr., Long-term l-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998 97 2123 2128
137. Cannon RO 3rd, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB, Geraci MF, Black BC, Uhde TW, Waclawiw MA, Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994 330 1411 1417. doi: 10.1056/NEJM199405193302003
138. Cox ID, Hann CM, Kaski JC, Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. Eur Heart J 1998 19 250 254
139. Sestito A, Lanza GA, Le Pera D, De Armas L, Sgueglia GA, Infusino F, Miliucci R, Tonali PA, Crea F, Valeriani M, Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X. Pain 2008 139 82 89. doi: 10.1016/j.pain.2008.03.015
140. Lanza GA, Sestito A, Sandric S, Cioni B, Tamburrini G, Barollo A, Crea F, De Seta F, Meglio M, Bellocci F, Maseri A, Spinal cord stimulation in patients with refractory anginal pain and normal coronary arteries. Ital Heart J 2001 2 25 30
141. Kitsou V, Xanthos T, Roberts R, Karlis GM, Padadimitriou L, Enhanced external counterpulsation: mechanisms of action and clinical applications. Acta Cardiol 2010 65 239 247. doi: 10.2143/AC.65.2.2047060
142. Kronhaus KD, Lawson WE, Enhanced external counterpulsation is an effective treatment for Syndrome X. Int J Cardiol 2009 135 256 257. doi: 10.1016/j.ijcard.2008.03.022
143. Asbury EA, Kanji N, Ernst E, Barbir M, Collins P, Autogenic training to manage symptomology in women with chest pain and normal coronary arteries. Menopause 2009 16 60 65. doi: 10.1097/GME.0b013e318184762e
144. Samim A, Nugent L, Mehta PK, Shufelt C, Bairey Merz CN, Treatment of angina and microvascular coronary dysfunction. Curr Treat Options Cardiovasc Med 2010 12 355 364. doi: 10.1007/s11936-010-0083-8